Analysis | Metabolite Name | Measured Value | Units | Group |
---|---|---|---|---|
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.3367 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.4072 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.4297 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.5734 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.5760 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6108 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6161 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6169 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6424 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6616 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6644 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6766 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6790 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6871 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6907 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6954 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7217 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7299 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7459 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7569 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7632 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7645 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7701 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7711 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7871 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7963 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8029 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8101 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8134 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8156 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8174 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8234 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8286 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8355 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8397 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8474 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8481 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8501 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8520 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8530 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8560 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8643 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8693 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8701 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8746 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8780 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8784 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8836 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8972 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8975 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8983 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9147 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9152 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9167 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9239 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9298 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9350 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9479 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9539 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9603 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9638 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9653 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9722 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9813 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9970 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0000 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0088 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0107 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0125 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0135 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0163 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0295 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0299 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0441 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0535 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0769 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0818 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0846 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0891 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0965 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1003 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1015 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1100 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1110 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1180 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1296 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1411 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1413 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1455 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1483 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1513 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1516 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1742 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1914 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2020 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2020 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2040 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2054 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2106 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2570 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2606 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2684 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2700 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2752 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2899 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2909 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3014 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3121 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3121 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3175 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3330 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3386 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3431 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3554 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3713 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3895 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4122 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4655 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4805 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.5051 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.5068 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.5086 | Peak area | Lean |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.5408 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.6036 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.6527 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.6700 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.6966 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.8297 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.0363 | Peak area | Obese non neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.4432 | Peak area | Obese neuropathy |
Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.6172 | Peak area | Lean |